Morgan Stanley: First coverage of INNOSCIENCE (02577) with a "market perform" rating and a target price of HK$95.
This line believes that the current valuation largely reflects high market expectations.
Morgan Stanley has released a research report stating that it is initiating coverage on INNOSCIENCE (02577) for the first time with a rating in line with the market. The target price is 95 Hong Kong dollars, equivalent to a forecasted P/E ratio of 34 times for next year. The bank believes that INNOSCIENCE is a leading gallium nitride power integrated circuit manufacturer and that the company is well positioned to benefit from secular growth drivers such as artificial intelligence data centers, Siasun Robot & Automation, and electric vehicles. The bank believes that the current valuation largely reflects high market expectations.
Related Articles

Guangdong Enpack Packaging (002846.SZ) three shareholders plan to collectively reduce their holdings by no more than 6% of the shares.
.png)
GF SEC(01776): "25 Guangfa 09" coupon rate is 1.99%

CEOVU (00798) spent a total of 1,029,000 Hong Kong dollars to repurchase 4.2 million shares on October 13th.
Guangdong Enpack Packaging (002846.SZ) three shareholders plan to collectively reduce their holdings by no more than 6% of the shares.

GF SEC(01776): "25 Guangfa 09" coupon rate is 1.99%
.png)
CEOVU (00798) spent a total of 1,029,000 Hong Kong dollars to repurchase 4.2 million shares on October 13th.

RECOMMEND

Comprehensive Subsidy Phase-Out: Is China’s Auto Market Nervous Ahead of Golden Week?
30/09/2025

“A+H” Listing Momentum Continues as 20 A‑Share Companies Plan Hong Kong IPOs, PCB Leaders Dongshan Precision and Hoshine Among Them
30/09/2025

Copper Poised as the “New Oil” as Western Grids Lag Behind China, Goldman Sachs Warns
30/09/2025